International Symposium on Immunobiologicals

International Symposium on Immunobiologicals | May 6-8, 2026 | Rio de Janeiro (BRA)

Mabion is pleased to announce its participation in the International Symposium on Immunobiologicals (ISI), one of the most prominent global events dedicated to the field of immunobiologicals. This initiative reflects our continued commitment to strengthening partnerships within the South American biopharma market.

The Summit, organized by Bio-Manguinhos/Fiocruz, brings together leading specialists, researchers, and healthcare professionals to explore developments in biopharmaceuticals, and vaccines. The symposium also serves as a platform to discuss advancements in technology, manufacturing, management, and market dynamics within this critical sector.

Our presence at ISI follows an invitation from the Instituto de Biologia Molecular do Paraná (IBMP), with whom Mabion is currently executing a framework agreement covering both development processes and the production of clinical trial materials. This collaboration marks an important step in expanding our footprint in the region and fostering long-term scientific and industrial cooperation.

Representing Mabion at the symposium will be Judyta Suskiewicz, Director of Business Development. Judyta played a key role in leading and successfully concluding the proposal process with IBMP, and her participation underscores the strategic importance of this partnership.

Mabion looks forward to engaging with partners and stakeholders at International Symposium on Immunobiologicals. We love to contribute to meaningful discussions, and further advancing our mission to support the development and accessibility of high-quality biopharmaceutical solutions worldwide.

Join us and register at the ISI summit website.